Akoya Set to Join Russell 3000® Index
MARLBOROUGH, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, is set...
News
Celsion Appoints Christine A. Pellizzari to its Board of Directors
Brings extensive biopharmaceutical legal background to the Board Appointment increases the size of Celsion’s Board from seven to eight Directors...
eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors
CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today...
AEON Biopharma Appoints Dr. Chad K. Oh as Chief Medical Officer to Lead Clinical Development of ABP-450 Across Several Therapeutic Indications
NEWPORT BEACH, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc., a private clinical-stage biopharmaceutical company focused on the...
EY Announces Florian Wegener of ZAGENO as an Entrepreneur Of The Year® 2021 New England Award Finalist
Celebrating the 35th class of unstoppable entrepreneurs who transform New England and BeyondCAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) --...
Intercept Appoints M. Michelle Berrey, M.D., M.P.H., as President of Research & Development and Chief Medical Officer
NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and...
electroCore Completes Sale of $1.4 Million of NJ NOL Tax Benefits
ROCKAWAY, NJ, June 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that...
eFFECTOR Therapeutics Doses First Patient in Phase 2b KICKSTART Clinical Trial
Clinical trial to assess safety and efficacy of tomivosertib in combination with KEYTRUDA® in patients with non-small cell lung cancerSAN...
Assembly Biosciences to Present Data from HBV Core Inhibitor Programs at The International Liver Congress™ EASL 2021
SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing...
PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference
CRANBURY, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
Equillium to Present at the JMP Securities Life Sciences Conference
LA JOLLA, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to...
NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences
WOBURN, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized...
USA Equities Corp Announces Co-Promotion Agreement with ENP Network for AllergiEnd® and Upcoming University of Miami CME Workshop
-Further Expanding Independent Practitioner Network and Industry Visibility- West Palm Beach, FL, June 09, 2021 (GLOBE NEWSWIRE) -- USA Equities...
CymaBay Therapeutics Announces Presentations During The International Liver Congress™ 2021
NEWARK, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
Starton Therapeutics Advances STAR-LLD Transdermal Lenalidomide Following Successful Skin Permeation Studies
PARAMUS, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc., a clinical stage biotechnology company transforming standard of care...
Avricore Health Corporate Update Summer 2021
VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased...
Applied Molecular Transport to Present at JMP Securities Life Sciences Conference
SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical...
Kymera Therapeutics to Present New Data Demonstrating both Single-agent and Combination Regressions in MYD88-mutant Lymphoma Preclinical Models with IRAKIMiD Degrader KT-413 at 16th ICML Meeting
Data demonstrate KT-413’s potential as a monotherapy and in combination with rituximab or BTK inhibitors, with potent antitumor activity in...
Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting
The market leader in transcranial magnetic stimulation will spotlight real-world clinical data on NeuroStar® Advanced Therapy for Mental HealthMALVERN, Pa.,...
Clover Health to Scale In-home Primary Care Program Through Direct Contracting
Program has driven reductions in hospital stays and medical expensesInks new partnerships with leading home-based care providers, Spiras Health and...